Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
GSS
United Kingdom
- London
- 26/01/2023
- Unknown
- $45,716,000
GSS brings global financial institutions together to deliver higher standards in compliance, providing a trusted platform to enhance and exchange information. The first service delivers sanctions transaction screening, built on industry standards and improved processes. Services under GSS are easily accessible to everyone, delivering greater effectiveness, improved efficiency and the reduction of friction.
- Industry Financial Services
- Website https://www.gss-rose.com/
- LinkedIn https://www.linkedin.com/company/global-screening-services/
Related People
Tom ScampionCo Founder
United Kingdom -
ND
I have over 25 years experience in the design, delivery and evaluation of financial crime systems and controls. I have led many of the largest global regulatory look-backs and remediation programmes in financial crime, as well as the design and delivery of financial crime operating models for major institutions. I have worked closely with regulators, law enforcement and counsel in the US, Europe and Asia and have spent time seconded to institutions to help deliver material change.
Before joining AlixPartners I was the Financial Crime head of EMEA for a leading big four firm.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)